Browse by Authors and Editors

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Jump to: Article
Number of items: 4.

Article

Al-Subhi, Nouf, Ali, Reem, Abdel-Fatah, Tarek, Moseley, Paul M., Chan, Stephen Y.T., Green, Andrew R., Ellis, Ian O., Rakha, Emad and Madhusudan, Srinivasan (2018) Targeting ataxia telangiectasia mutated and Rad3 related kinase (ATR) in PTEN deficient breast cancers for personalized therapy. Breast Cancer Research and Treatment . ISSN 1573-7217

Machado, Lee R, Moseley, Paul M., Moss, Robert, Deen, Suha, Nolan, Christopher C., Spendlove, Ian, Ramage, Judith M., Chan, Stephen Y.T. and Durrant, Lindy (2017) High mobility group protein B1 is a predictor of poor survival in ovarian cancer. Oncotarget . ISSN 1949-2553

Abdel-Fatah, Tarek M.A., Agarwal, Devika, Liu, Dong-Xu, Russell, Roslin, Rueda, Oscar M., Liu, Karen, Xu, Bing, Moseley, Paul M., Green, Andrew R., Pockley, Alan G., Rees, Robert C., Caldas, Carlos, Ellis, Ian O., Ball, Graham R. and Chan, Stephen Y.T. (2016) SPAG5 as a prognostic biomarker and chemotherapy sensitivity predictor in breast cancer: a retrospective, integrated genomic, transcriptomic, and protein analysis. Lancet Oncology, 17 (7). pp. 1004-1018. ISSN 1474-5488

Arora, Arvind, Abdel-Fatah, Tarek, Agarwal, Devika, Doherty, Rachel, Moseley, Paul M., Aleskandarany, Mohammed A., Green, Andrew R., Ball, Graham, Alshareeda, Alaa, Rakha, Emad, Chan, Stephen Y.T., Ellis, Ian O. and Madhusudan, Srinivasan (2015) Transcriptomic and protein expression analysis reveals clinicopathological significance of bloom syndrome helicase (BLM) in breast cancer. Molecular Cancer Therapeutics, 14 (4). pp. 1057-1065. ISSN 1538-8514

This list was generated on Thu Mar 28 17:58:39 2024 UTC.